Tretinoin tocoferil as a possible Differentiation-Inducing agent against myelomonocytic leukemia

References

• Tallman M. S., Wiernik P. H. Retinoids in cancer treatment. J. Clin. Pharmacol 1992; 32: 868–888
   PubMed Web of Science ®Google Scholar
• Warrell R. P., Jr. Application for retinoids in cancer therapy. Semin. Hematol 1994; 31(Suppl. 5)1–13
   PubMedGoogle Scholar
• Meydani M. Vitamin E. Lancet 1995; 345: 170–175
   PubMed Web of Science ®Google Scholar
• Makishima M., Kanatani Y., Yamamoto-Yamaguchi Y., Honma Y. Enhancement of activity of 1α,25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an α-tocopherol ester of all-trans retinoic acid. Blood 1996; 87: 3384–3394
   PubMed Web of Science ®Google Scholar
• Breitman T. R., Selonick S. E., Collins S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA 1980; 77: 2936–2940
   PubMed Web of Science ®Google Scholar
• Honma Y., Takenaga K., Kasukabe T., Hozumi M. Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids. Biochem. Biophys. Res. Commun 1980; 95: 507–512
   PubMed Web of Science ®Google Scholar
• Breitman T. R., Collins S. J., Keene B. R. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 1981; 57: 1000–1004
   PubMed Web of Science ®Google Scholar
• Honma Y., Fujita Y., Kasukabe T., Hozumi M., Sampi. K. Sakurai M., Tsushima S., Nomura H. Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid cell line HL-60. Eur. J. Cancer. Clin. Oncol 1983; 19: 251–261
   PubMedGoogle Scholar
• Huang M., Ye Y., Chen S., Chai J., Lu J., Zhoa L., Gu L., Wang Z. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–572
   PubMed Web of Science ®Google Scholar
• Degos L., Dombret H., Chomienne C., Daniel M. T, Micléa J. M, Chastang C., Castaigne S., Fenaux P. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995; 85: 2643–-2653
   PubMed Web of Science ®Google Scholar
• Petkovich M., Brand N. J., Krust A., Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444–450
   PubMed Web of Science ®Google Scholar
• Giguere V., Ong E. S., Segui P., Evans R. M. Identification of a receptor for the morphogen retinoic acid. Nature 1987; 330: 624–629
   PubMed Web of Science ®Google Scholar
• Brand N., Petkovich M., Krust A., Chambon P., de-Thá H., Marchio A., Tiollais P., Dejean A. Identification of a second human retinoic acid receptor. Nature 1988; 332: 850–853
   PubMed Web of Science ®Google Scholar
• Benbrook D., Lernhardt E., Pfahl M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 1988; 333: 669–672
   PubMed Web of Science ®Google Scholar
• Krust A., Kastner P., Petkovich M., Zelent A., Chambon P. A third human retinoic acid receptor, hRAR-γ. Proc. Natl. Acad. Sci. USA 1989; 86: 5310–5314
   PubMed Web of Science ®Google Scholar
• Levin A. A., Sturzenbecker L. J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A., Grippo J. F. 9-cis Retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 1992; 355: 359–361
   PubMed Web of Science ®Google Scholar
• Heyman R. A., Mangelsdorf D. J., Dyck J. A., Stein R. B., Eichele G., Evans R. M., Thaller C. 9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992; 68: 397–406
   PubMed Web of Science ®Google Scholar
• Mangelsdorf D. J., Borgmeyer U., Heyman R. A., Zhou J. Y., Ong E. S., Oro A. E., Kakizuka A., Evans R. M. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dee 1992; 6: 329–344
   PubMed Web of Science ®Google Scholar
• Kakizuka A., Miller M. H., Jr, Umesono K., Warrell R. P., Jr, Frankel S. R., Murty V. V.V.S., Dmitrovsky E., Evans R. M. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 1991; 66: 663–674
   PubMed Web of Science ®Google Scholar
• Tallman M. S. All-trans retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies. Semin. Hematol 1994; 31(Suppl. 5)38–48
   PubMedGoogle Scholar
• Lowe N. J., David M. New retinoids for dermatologic diseases. Use and toxicity. Dermatol. Clin 1988; 6: 539–552
   PubMed Web of Science ®Google Scholar
• Warrell R. P., Jr, de-Thá H., Wang Z. Y, Degos L. Acute promyelocytic leukemia. N. Engl. J. Med 1993; 329: 177–189
   PubMed Web of Science ®Google Scholar
• Miller V. A., Rigas J. R., Benedetti F. M., Verret A. L., Tong W. P., Kris M. G., Gill G. M., Loewen G. R., Truglia J. A., Ulm E. H., Warrell R. P., Jr. Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid. Clin. Cancer Res 1996; 2: 471–475
   PubMed Web of Science ®Google Scholar
• Lohnes D., Kastner P., Dierich A., Mark M., LeMeur M., Chambon P. Function of retinoic acid receptor γ in the mouse. Cell 1993; 73: 643–658
   PubMed Web of Science ®Google Scholar
• Mendelsohn C., Lohnes D., Deimo D., Lufkin T., LeMeur M., Chambon P., Mark M. Function of the retinoic acid receptors (RARs) during development. (II) Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 1994; 120: 2749–2771
   PubMed Web of Science ®Google Scholar
• Kastner P., Mark M., Leid M., Gansmuller A., Chin W., Grondona J. M., Décimo D., Krezel W., Dierich A., Chambon P. Abnormal spermatogenesis in RXRβ mutant mice. Genes Dev 1996; 10: 80–92
   PubMed Web of Science ®Google Scholar
• Kamm J. J. Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoids. J. Am. Acad. Dermatol 1982; 6: 652–659
   PubMed Web of Science ®Google Scholar
• Hashimoto Y., Shudo K. Retinoids and their nuclear receptors. Cell Biol. Rev 1991; 25: 209–230
   Google Scholar
• Cook M. G., McNamara P. Effect of dietary vita-min E on dimethylhydrazine-induced colonic tumors in mice. Cancer Res 1980; 40: 1329–1331
   PubMed Web of Science ®Google Scholar
• Gridley G., McLaughlin J. K., Block G., Blot W. J., Gluch M., Fraumeni J. F., Jr. Vitamin supplement use and reduced risk of oral and pharyngeal cancer. Am. J. Epidemiol 1992; 135: 1083–1092
   PubMed Web of Science ®Google Scholar
• Blot W. J., Li J. Y, Taylor P. R., Guo W., Dawsey S., Wang G. W, Yang C. S., Zheng S. F, Gail M., Li G. Y, Yu Y., Liu B., Tangrea J., Sun Y., Liu F., Fraumeni J. F., Jr, Zhang Y. H, Li B. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst 1993; 85: 1483–1492
   PubMed Web of Science ®Google Scholar
• Taylor P. R., Li B., Dawsey S. M., Li J. Y, Yang C. S., Guo W., Blot W. J., Linxian Nutrition Intervention Trials Study Group. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Cancer Res 1994; 54(Suppl 1)2029–2031
   Google Scholar
• Prasad K. N., Edwards-Prasad J. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res 1982; 42: 550–555
   PubMed Web of Science ®Google Scholar
• Turley J. M., Funakoshi S., Ruscetti F. W., Kasper J., Murphy W. J., Longo D. L., Birchenall-Roberts M. C. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor β. Cell Growth Differ 1995; 6: 635–663
   Google Scholar
• Turley J. M., Sanders B. G., Kline K. RRR-α Tocopheryl succinate modulation of human promyelocytic leukemia (HL-60) cell proliferation and differentiation. Nutr. Cancer 1992; 18: 201–213
   PubMed Web of Science ®Google Scholar
• Yasuno H., Kishimoto S., Yamanishi K., Konishi K., Oka F., Oonishi M., Kagami K., Old M., Maeda M., Sasaki Y., Komori Y., Wakabayashi S., Miura H., Inoue Y., Miyashita A., Tamaoki K., Okuda R., Ryu F. Evaluation of the effects of L-300 ointment in the treatment of intractable skin ulcers. Rinsho-iyaku (in Japanese) 1990; 6: 2481–2490
   Google Scholar
• Sakyo K., Ishikawa T., Nishiki K., Otsuka N., Ito A., Mori Y. Stimulating effect of tocoretinate on granulation and angiogenesis. Pharmacometrics (in Japanese) 1992; 43: 87–95
   Google Scholar
• Hamada H., Sakyo K., Tanaka H., Ogawa O., Nishiki K. Effect of tocoretinate on migration of cells. Pharmacometrics (in Japanese) 1992; 43: 97–102
   Google Scholar
• Sakyo K., Otsuka N., Hamada H., Nakaya N., Nakazawa T., Nakahara Y., Naruke T., Nishiki K., Ito A., Mori Y. Effect of tocoretinate on proliferation of normal human skin fibroblasts. Pharmacometrics (in Japanese) 1992; 43: 103–110
   Google Scholar
• Mori Y., Hatamochi A., Takeda K., Ueki H. Effects of tretinoin tocoferil on gene expression of the extra-cellular matrix components in human dermal fibroblasts in vitro. J. Dermatol. Sci 1994; 8: 233–238
   PubMedGoogle Scholar
• Kuroda T., Nakazawa T., Watanabe T., Kawashima K., Arai I., Nakahara Y., Naruke T., Nishiki K., Inomata N. Metabolic fate of tocoretinate (3). Metabolism of 14C-tocoretinate in rats and dogs. Pharmacometrics (in Japanese) 1992; 43: 221–226
   Google Scholar
• Harada Y., Narita H., Kashiwagi H., Misawa N., Takagi H., Takita S., Inomata N. Acute toxicity study of tocoretinate in mice, rats and dogs. Pharmacometrics (in Japanese) 1992; 43: 227–230
   Google Scholar
• Okazaki S., Mochizuki M., Masuda T., Takagi H., Takita S., Inomata N. A 12-month oral toxicity study of tocoretinate in rats. Pharmacometrics (in Japanese) 1992; 251–258
   Google Scholar
• Ohta R., Hashimoto Y., Mizutani M., Misawa N., Inomata N. Reproductive and developmental toxicity study of tocoretinate (I). Effects on reproductive function and fertility in rats. Pharmacometrics (in Japanese) 1992; 43: 303–310
   Google Scholar
• Tanaka N., Murakami Y., Noguchi O., Narita H., Hamada S., Ohashi M., Misawa N., Inomata N. Reproductive and developmental toxicity study of tocoretinate (III). Teratological study in rabbits by oral administration. Pharmacometrics (in Japanese) 1992; 43: 323–327
   Google Scholar
• Besa E. C., Abrahm J., Bartholomew M. J., Hyzinski M., Nowell P. C. Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alphatocopherol. Am. J. Med 1990; 89: 739–747
   PubMed Web of Science ®Google Scholar
• Bikle D. D. Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. Endocr. Rev 1992; 13: 765–784
   PubMed Web of Science ®Google Scholar
• Koeffler H. P., Hirji K., Itri L. the Southern California Leukemia Group. (1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat. Rep 1985; 69: 1399–1407
   PubMedGoogle Scholar
• Nakazawa T., Kuroda T., Arai I., Nakahara Y., Naruke T., Nishiki K., Inomata N., Tahara Y., Yanai M., Sakuma S., Kimura T. Metabolic fate of tocoretinate (1). Absorption and excretion of 14C-tocoretinate in rats and dogs. Pharmacometrics (in Japanese) 1992; 43: 205–210
   Google Scholar
• Taimi M., Chateau M. T, Cabane S., Marti J. Synergistic effect of retinoic acid and 1,25-dihydroxyvitamin D3 on the differentiation of the human monocytic cell line U937. Leuk. Res 1991; 15: 1145–1152
   PubMed Web of Science ®Google Scholar
• Brown G., Bunce C. M., Rowlands D. C., Williams G. R. All-trans retinoic acid and 1α,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes. Leukemia 1994; 8: 806–815
   PubMed Web of Science ®Google Scholar
• Akiyama H., Nakamura N., Nagasaki S., Sakamaki H., Onozawa Y. Hypercalcaemia due to all-trans retinoic acid. Lancet 1992; 339: 308–309
   PubMed Web of Science ®Google Scholar
• Sakakibara M., Ichikawa M., Amano Y., Matsuzawa S., Agematsu K., Mori T., Koike K., Nakahata T., Komiyama A. Hypercalcemia associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Leuk. Res 1993; 17: 441–443
   PubMed Web of Science ®Google Scholar
• Suzumiya J., Asahara F., Katakami H., Kimura N., Hisano S., Okumura M., Ohno R. Hypercalcaemia caused by all-trans retinoic acid treatment of acute promyelocytic leukaemia; case report. Eur. J. Haematol 1994; 53: 126–127
   PubMed Web of Science ®Google Scholar
• Tachibana Y., Tsuji M., Yokoyama S., Tejima T. Synthetic studies on active forms of vitamin D and their analogues. J. Syn. Org. Chem., Japan (in Japanese) 1995; 53: 791–801
   Web of Science ®Google Scholar